4DMedical™ CT:VQ™
Contrast-level insights. No injections
4DMedical™ CT:VQ™
Contrast-level insights. No injections
CT:VQ is a software-as-a-service (SaaS), post-processing solution that transforms routine, non-contrast chest CTs into comprehensive, quantitative regional ventilation and perfusion reports—without injected contrast or radioisotopes. Works on existing DICOM studies, including retrospective analyses
4DMedical™ CT:VQ™
Features
Non-contrast ventilation and perfusion imaging from standard chest CTs
Uses non contrast CT; no injections or radioisotopes with Quantitative, color-coded maps with structured reports
Widely available
Uses ubiquitous CT in the U.S. to enable functional lung imaging on existing scanners—no new hardware. Works on existing DICOM studies, including retrospective analyses/ Works across community hospitals, academic centers, and outpatient imaging centers.
Helps to reduce supply savings
Less contrast media, IV placement, and premedication.
Related products
- Philips is offering the XV LVAS™ from 4DMedical, a Software as a Service (SaaS) that uses fluoroscopic lung images from existing hospital equipment to quantify regional lung ventilation in a comprehensive but easy-to-interpret report that includes 4D video visualizations. Areas of high and low ventilation are highlighted and ventilation heterogeneity – a recognized indicator of lung health – is quantified. XV LVAS™ provides regional quantification of lung function, including Lung Volume, Ventilation Heterogeneity and Ventilation Defect Percentage with four-dimensional imaging – 3D + time. Includes easy-to-read visualization of regional lung ventilation and actionable insights into lung function to better characterize and quantify respiratory conditions and symptoms including lung health assessment for toxic exposure, VA-specific lung cancer screening, COPD, and Sarcoidosis/long COVID, with no need for contrast agents.
- The clinical presentation of unexplained dyspnea, or shortness of breath, can be complex. Imaging plays a crucial role in the diagnostic process, but anatomical findings can overlap, lag or precede clinical symptoms. CT lung ventilation analysis significantly enhances diagnostic reports, providing actionable information. Philips offers the 4DMedical™ CT LVAS™ as a Software-as-a-Service (SasS) to allow clinicians to better characterize lung conditions and detect associated regional lung changes. CT-LVAS™ provides regional quantification of lung function, including lung volumes, ventilation heterogeneity, and ventilation defect percentage with easy-to-read, color-coded visualization. Gives detailed, actionable insights into lung function to better characterize and quantify respiratory conditions and symptoms including lung health assessment for toxic exposure, VA-specific lung cancer screening, COPD, Sarcoidosis/long COVID, and more. Compatible with existing imaging equipment with no need for contrast agents.
- Use advanced visualization and algorithm-based technology to turn standard medical imaging into personalized medicine by transforming the way clinical conditions are discovered, diagnosed, treated and managed.
Disclaimer
Philips is an authorized partner of 4DMedical™. CT:VQ™ is a registered trademark of 4DMedical™ or its affiliates.